FierceBiotech ٩ يناير ٢٠٢٦ Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
FierceBiotech ٩ يناير ٢٠٢٦ Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
FierceBiotech ٩ يناير ٢٠٢٦ Illumina hires former NHGRI Director Eric Green as new chief medical officer
FierceBiotech ٩ يناير ٢٠٢٦ Roche returns to MediLink with promise of $570M near-term payments for another ADC
FierceBiotech ٩ يناير ٢٠٢٦ Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
FierceBiotech ٨ يناير ٢٠٢٦ Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
FierceBiotech ٨ يناير ٢٠٢٦ Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
FierceBiotech ٨ يناير ٢٠٢٦ Startup Spiro Medical snares $67M in series A funding for asthma treatment
FierceBiotech ٨ يناير ٢٠٢٦ Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
FierceBiotech ٨ يناير ٢٠٢٦ Diagonal moves forward with $125M series B round, plots first-in-human study this year